INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Spectrum Pharmaceuticals, Inc. & Encourages Inve...
October 23 2015 - 5:27PM
Business Wire
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it
is investigating claims of potential misrepresentations by Spectrum
Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI).
The investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to
investors.
If you purchased or otherwise acquired Spectrum shares and would
like more information regarding the investigation, we advise you to
contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650
Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation concerns whether the Company violated Sections
10(b) and 20(a) of the Securities Exchange Act of 1934. On October
23, 2015, Spectrum announced that it has received a Complete
Response Letter from the U.S. Food and Drug Administration (FDA) in
response to its New Drug Application seeking clearance for Evomela,
indicating that the FDA cannot approve the application in its
present form. When the truth was revealed, shares dropped causing
investors harm.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151023005952/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.
800-977-7401Brian Schall, Esq.
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024